I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Moretto, R.
708
results:
Search for persons
X
Format
Online (708)
Mediatypes
E-Books (6)
Articles (Online) (342)
Bookchapter (Online) (5)
OpenAccess-fulltext (355)
Languages
english (590)
more...
french (1)
portuguese (16)
italian (2)
less...
Sorted by: Relevance
Sorted by: Year
?
1
158TiP Exploiting circulating tumor DNA (ctDNA) to intensif..:
Conca, V.
;
Vetere, G.
;
Moretto, R.
...
Annals of Oncology. 35 (2024) - p. S70 , 2024
Link:
https://doi.org/10.1016/..
?
2
113P p16 immunohistochemical (IHC) expression (exp) predict..:
Studiale, V.
;
Germani, M.M.
;
Moretto, R.
...
Annals of Oncology. 35 (2024) - p. S53 , 2024
Link:
https://doi.org/10.1016/..
?
3
Predicting early recurrence after resection of initially un..:
Moretto, R.
;
Germani, M.M.
;
Borelli, B.
...
ESMO Open. 9 (2024) 4 - p. 102991 , 2024
Link:
https://doi.org/10.1016/..
?
4
63P FOLFOXIRI/bevacizumab (bev) versus doublets/bev as init..:
Marmorino, F.
;
Antoniotti, C.
;
Meinert, F.M.
...
Annals of Oncology. 35 (2024) - p. S30 , 2024
Link:
https://doi.org/10.1016/..
?
5
53P Trifluridine/tipiracil plus capecitabine and bevacizuma..:
Ciracì, P.
;
Conca, V.
;
Moretto, R.
...
Annals of Oncology. 35 (2024) - p. S25-S26 , 2024
Link:
https://doi.org/10.1016/..
?
6
Encorafenib plus cetuximab with or without binimetinib in p..:
Boccaccino, A.
;
Borelli, B.
;
Intini, R.
...
ESMO Open. 7 (2022) 3 - p. 100506 , 2022
Link:
https://doi.org/10.1016/..
?
7
Efficacy of FOLFOXIRI plus bevacizumab in liver-limited met..:
Cremolini, Chiara
;
Casagrande, Mariaelena
;
Loupakis, Fotios
...
European Journal of Cancer. 73 (2017) - p. 74-84 , 2017
Link:
https://doi.org/10.1016/..
?
8
The abundance of the Calvin–Benson proteoforms is not affec..:
Baldassi, Amanda C
;
Robbins, Julia
;
Moretto, Leticia R
...
Plant Stress. 12 (2024) - p. 100438 , 2024
Link:
https://doi.org/10.1016/..
?
9
Corticosteroid injection into Achilles tendon in rabbits: H..:
Godoy-Santos, A.L.
;
Dinhane, K.
;
Todorovic-Fabro, A.
...
Foot and Ankle Surgery. 22 (2016) 2 - p. 20 , 2016
Link:
https://doi.org/10.1016/..
?
10
Pilot-scale investigation on the feasibility of simultaneou..:
Subtil, Eduardo Lucas
;
Silva, Marina Victoretti
;
Lotto, Bruna Araújo
..
Journal of Water Process Engineering. 32 (2019) - p. 100995 , 2019
Link:
https://doi.org/10.1016/..
?
11
Immune-related pan-cancer gene expression signatures of pat..:
D'Angelo A
;
Kilili H
;
Chapman R
...
info:eu-repo/semantics/altIdentifier/pmid/36649303. , 2023
Link:
https://hdl.handle.net/1..
?
12
Encorafenib plus cetuximab with or without binimetinib in p..:
Boccaccino, A
;
Borelli, B
;
Intini, R
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271503/. , 2022
Link:
http://www.ncbi.nlm.nih...
?
13
Treatments after progression to first-line FOLFOXIRI and be..:
Rossini D
;
Lonardi S
;
Antoniotti C
...
info:eu-repo/semantics/altIdentifier/pmid/33024268. , 2021
Link:
http://hdl.handle.net/11..
?
14
The pan-immune-inflammation value is a new prognostic bioma..:
Fuca G
;
Guarini V
;
Antoniotti C
...
info:eu-repo/semantics/altIdentifier/pmid/32424148. , 2020
Link:
https://hdl.handle.net/1..
?
15
Upfront FOLFOXIRI plus bevacizumab and reintroduction after..:
Cremolini C
;
Antoniotti C
;
Rossini D
...
info:eu-repo/semantics/altIdentifier/pmid/32164906. , 2020
Link:
http://hdl.handle.net/11..
1-15